Global Oncology Ablation Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Oncology Ablation market size was valued at US$ 2823 million in 2025 and is forecast to a readjusted size of US$ 5594 million by 2032 with a CAGR of 10.3% during review period.
Oncology ablation refers to a class of minimally invasive, image-guided therapeutic procedures that deliver controlled physical energy—such as radiofrequency, microwave, cryogenic, laser, or high-intensity focused ultrasound—directly to tumor tissues to induce irreversible cell death. Typically performed via percutaneous or endoluminal approaches, it integrates imaging navigation, energy delivery systems, and applicators to achieve precise and controlled treatment. With advantages including minimal invasiveness, rapid recovery, and repeatability, oncology ablation is widely used in treating solid tumors such as liver, lung, kidney, and bone metastases. It serves both as an alternative to surgery and as part of multimodal therapy. As precision medicine and minimally invasive care evolve, oncology ablation is increasingly expanding toward curative applications in early-stage cancers and long-term disease management, becoming a cornerstone of modern oncology treatment.The average gross profit margin of this product is 72%.
Driven by national cancer control initiatives and the expansion of early screening systems, oncology treatment is shifting from late-stage intervention to early precision care, creating significant opportunities for ablation procedures. Corporate disclosures and investment research indicate continuous advancements in RF, microwave, and cryo technologies, along with improvements in imaging fusion and intelligent navigation, enhancing treatment precision and safety. At the same time, hospitals’ increasing demand for minimally invasive procedures to improve efficiency and reduce hospital stays is accelerating the transition of ablation from an adjunctive option to a standardized treatment pathway.
Despite expanding applications, variability in efficacy for complex or large tumors remains a challenge, with outcomes highly dependent on operator expertise. Industry standards, procedural guidelines, and clinical pathways are still evolving, while disparities in healthcare resources across regions limit widespread adoption. Additionally, high costs of advanced equipment and consumables, along with delays in reimbursement and guideline updates, continue to constrain market penetration.
Clinical practice is shifting from surgery-centric approaches to multidisciplinary, minimally invasive treatment models, with increasing adoption of ablation in liver cancer, lung nodules, and thyroid diseases. Growing patient demand for reduced trauma, faster recovery, and improved quality of life is driving the expansion of outpatient and day-care procedures. Furthermore, the trend toward chronic disease management in oncology is increasing demand for recurrence control and long-term care, establishing a stable and sustainable clinical demand base for ablation therapies.
Upstream components include RF power modules, microwave generators, cryogenic systems, medical-grade metals, and polymer insulation materials, all critical to treatment efficacy and safety. Industry disclosures suggest that advancements in electronics manufacturing and precision engineering are enabling partial localization of key components, although high-end sensors and imaging integration systems still rely on imports. The supply chain is evolving toward integrated platforms, with upstream players expanding technological capabilities to enhance value-added and strengthen overall competitiveness.
This report is a detailed and comprehensive analysis for global Oncology Ablation market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oncology Ablation market size and forecasts, in consumption value ($ Million), 2021-2032
Global Oncology Ablation market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Oncology Ablation market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Oncology Ablation market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oncology Ablation market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncology Ablation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology Ablation, with revenue, gross margin, and global market share of Oncology Ablation from 2021 to 2026.
Chapter 3, the Oncology Ablation competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Oncology Ablation market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Ablation.
Chapter 13, to describe Oncology Ablation research findings and conclusion.
Oncology ablation refers to a class of minimally invasive, image-guided therapeutic procedures that deliver controlled physical energy—such as radiofrequency, microwave, cryogenic, laser, or high-intensity focused ultrasound—directly to tumor tissues to induce irreversible cell death. Typically performed via percutaneous or endoluminal approaches, it integrates imaging navigation, energy delivery systems, and applicators to achieve precise and controlled treatment. With advantages including minimal invasiveness, rapid recovery, and repeatability, oncology ablation is widely used in treating solid tumors such as liver, lung, kidney, and bone metastases. It serves both as an alternative to surgery and as part of multimodal therapy. As precision medicine and minimally invasive care evolve, oncology ablation is increasingly expanding toward curative applications in early-stage cancers and long-term disease management, becoming a cornerstone of modern oncology treatment.The average gross profit margin of this product is 72%.
Driven by national cancer control initiatives and the expansion of early screening systems, oncology treatment is shifting from late-stage intervention to early precision care, creating significant opportunities for ablation procedures. Corporate disclosures and investment research indicate continuous advancements in RF, microwave, and cryo technologies, along with improvements in imaging fusion and intelligent navigation, enhancing treatment precision and safety. At the same time, hospitals’ increasing demand for minimally invasive procedures to improve efficiency and reduce hospital stays is accelerating the transition of ablation from an adjunctive option to a standardized treatment pathway.
Despite expanding applications, variability in efficacy for complex or large tumors remains a challenge, with outcomes highly dependent on operator expertise. Industry standards, procedural guidelines, and clinical pathways are still evolving, while disparities in healthcare resources across regions limit widespread adoption. Additionally, high costs of advanced equipment and consumables, along with delays in reimbursement and guideline updates, continue to constrain market penetration.
Clinical practice is shifting from surgery-centric approaches to multidisciplinary, minimally invasive treatment models, with increasing adoption of ablation in liver cancer, lung nodules, and thyroid diseases. Growing patient demand for reduced trauma, faster recovery, and improved quality of life is driving the expansion of outpatient and day-care procedures. Furthermore, the trend toward chronic disease management in oncology is increasing demand for recurrence control and long-term care, establishing a stable and sustainable clinical demand base for ablation therapies.
Upstream components include RF power modules, microwave generators, cryogenic systems, medical-grade metals, and polymer insulation materials, all critical to treatment efficacy and safety. Industry disclosures suggest that advancements in electronics manufacturing and precision engineering are enabling partial localization of key components, although high-end sensors and imaging integration systems still rely on imports. The supply chain is evolving toward integrated platforms, with upstream players expanding technological capabilities to enhance value-added and strengthen overall competitiveness.
This report is a detailed and comprehensive analysis for global Oncology Ablation market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oncology Ablation market size and forecasts, in consumption value ($ Million), 2021-2032
Global Oncology Ablation market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Oncology Ablation market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Oncology Ablation market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Oncology Ablation
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oncology Ablation market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Microwave Ablation
- Radiofrequency Ablation
- Cryoablation
- High-Intensity Focused Ultrasound (HIFU)
- Others
- Thermal
- Cryogenic
- Percutaneous
- Laparoscopic
- Open
- Liver Cancer
- Lung Cancer
- Breast Cancer
- Other
- Chongqing Haifu Medical
- AngioDynamics
- Boston Scientific
- Medtronic
- Yigao Medical
- Haijieya
- Beijing Weierfu
- Micro Tech Medical
- Better Medical
- Vison Medical
- Shanghai Maide
- HealthTronics
- J &J
- EDAP TMS
- Sonacare Medical
- Misonix
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncology Ablation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology Ablation, with revenue, gross margin, and global market share of Oncology Ablation from 2021 to 2026.
Chapter 3, the Oncology Ablation competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Oncology Ablation market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Ablation.
Chapter 13, to describe Oncology Ablation research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncology Ablation by Type
1.3.1 Overview: Global Oncology Ablation Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Oncology Ablation Consumption Value Market Share by Type in 2025
1.3.3 Microwave Ablation
1.3.4 Radiofrequency Ablation
1.3.5 Cryoablation
1.3.6 High-Intensity Focused Ultrasound (HIFU)
1.3.7 Others
1.4 Classification of Oncology Ablation by Energy Source
1.4.1 Overview: Global Oncology Ablation Market Size by Energy Source: 2021 Versus 2025 Versus 2032
1.4.2 Global Oncology Ablation Consumption Value Market Share by Energy Source in 2025
1.4.3 Thermal
1.4.4 Cryogenic
1.5 Classification of Oncology Ablation by Procedure Type
1.5.1 Overview: Global Oncology Ablation Market Size by Procedure Type: 2021 Versus 2025 Versus 2032
1.5.2 Global Oncology Ablation Consumption Value Market Share by Procedure Type in 2025
1.5.3 Percutaneous
1.5.4 Laparoscopic
1.5.5 Open
1.6 Global Oncology Ablation Market by Application
1.6.1 Overview: Global Oncology Ablation Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Liver Cancer
1.6.3 Lung Cancer
1.6.4 Breast Cancer
1.6.5 Other
1.7 Global Oncology Ablation Market Size & Forecast
1.8 Global Oncology Ablation Market Size and Forecast by Region
1.8.1 Global Oncology Ablation Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Oncology Ablation Market Size by Region, (2021-2032)
1.8.3 North America Oncology Ablation Market Size and Prospect (2021-2032)
1.8.4 Europe Oncology Ablation Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Oncology Ablation Market Size and Prospect (2021-2032)
1.8.6 South America Oncology Ablation Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Oncology Ablation Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Chongqing Haifu Medical
2.1.1 Chongqing Haifu Medical Details
2.1.2 Chongqing Haifu Medical Major Business
2.1.3 Chongqing Haifu Medical Oncology Ablation Product and Solutions
2.1.4 Chongqing Haifu Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Chongqing Haifu Medical Recent Developments and Future Plans
2.2 AngioDynamics
2.2.1 AngioDynamics Details
2.2.2 AngioDynamics Major Business
2.2.3 AngioDynamics Oncology Ablation Product and Solutions
2.2.4 AngioDynamics Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 AngioDynamics Recent Developments and Future Plans
2.3 Boston Scientific
2.3.1 Boston Scientific Details
2.3.2 Boston Scientific Major Business
2.3.3 Boston Scientific Oncology Ablation Product and Solutions
2.3.4 Boston Scientific Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Boston Scientific Recent Developments and Future Plans
2.4 Medtronic
2.4.1 Medtronic Details
2.4.2 Medtronic Major Business
2.4.3 Medtronic Oncology Ablation Product and Solutions
2.4.4 Medtronic Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Medtronic Recent Developments and Future Plans
2.5 Yigao Medical
2.5.1 Yigao Medical Details
2.5.2 Yigao Medical Major Business
2.5.3 Yigao Medical Oncology Ablation Product and Solutions
2.5.4 Yigao Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Yigao Medical Recent Developments and Future Plans
2.6 Haijieya
2.6.1 Haijieya Details
2.6.2 Haijieya Major Business
2.6.3 Haijieya Oncology Ablation Product and Solutions
2.6.4 Haijieya Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Haijieya Recent Developments and Future Plans
2.7 Beijing Weierfu
2.7.1 Beijing Weierfu Details
2.7.2 Beijing Weierfu Major Business
2.7.3 Beijing Weierfu Oncology Ablation Product and Solutions
2.7.4 Beijing Weierfu Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Beijing Weierfu Recent Developments and Future Plans
2.8 Micro Tech Medical
2.8.1 Micro Tech Medical Details
2.8.2 Micro Tech Medical Major Business
2.8.3 Micro Tech Medical Oncology Ablation Product and Solutions
2.8.4 Micro Tech Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Micro Tech Medical Recent Developments and Future Plans
2.9 Better Medical
2.9.1 Better Medical Details
2.9.2 Better Medical Major Business
2.9.3 Better Medical Oncology Ablation Product and Solutions
2.9.4 Better Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Better Medical Recent Developments and Future Plans
2.10 Vison Medical
2.10.1 Vison Medical Details
2.10.2 Vison Medical Major Business
2.10.3 Vison Medical Oncology Ablation Product and Solutions
2.10.4 Vison Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Vison Medical Recent Developments and Future Plans
2.11 Shanghai Maide
2.11.1 Shanghai Maide Details
2.11.2 Shanghai Maide Major Business
2.11.3 Shanghai Maide Oncology Ablation Product and Solutions
2.11.4 Shanghai Maide Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Shanghai Maide Recent Developments and Future Plans
2.12 HealthTronics
2.12.1 HealthTronics Details
2.12.2 HealthTronics Major Business
2.12.3 HealthTronics Oncology Ablation Product and Solutions
2.12.4 HealthTronics Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 HealthTronics Recent Developments and Future Plans
2.13 J &J
2.13.1 J &J Details
2.13.2 J &J Major Business
2.13.3 J &J Oncology Ablation Product and Solutions
2.13.4 J &J Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 J &J Recent Developments and Future Plans
2.14 EDAP TMS
2.14.1 EDAP TMS Details
2.14.2 EDAP TMS Major Business
2.14.3 EDAP TMS Oncology Ablation Product and Solutions
2.14.4 EDAP TMS Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 EDAP TMS Recent Developments and Future Plans
2.15 Sonacare Medical
2.15.1 Sonacare Medical Details
2.15.2 Sonacare Medical Major Business
2.15.3 Sonacare Medical Oncology Ablation Product and Solutions
2.15.4 Sonacare Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Sonacare Medical Recent Developments and Future Plans
2.16 Misonix
2.16.1 Misonix Details
2.16.2 Misonix Major Business
2.16.3 Misonix Oncology Ablation Product and Solutions
2.16.4 Misonix Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Misonix Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Oncology Ablation Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Oncology Ablation by Company Revenue
3.2.2 Top 3 Oncology Ablation Players Market Share in 2025
3.2.3 Top 6 Oncology Ablation Players Market Share in 2025
3.3 Oncology Ablation Market: Overall Company Footprint Analysis
3.3.1 Oncology Ablation Market: Region Footprint
3.3.2 Oncology Ablation Market: Company Product Type Footprint
3.3.3 Oncology Ablation Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Oncology Ablation Consumption Value and Market Share by Type (2021-2026)
4.2 Global Oncology Ablation Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Oncology Ablation Consumption Value Market Share by Application (2021-2026)
5.2 Global Oncology Ablation Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Oncology Ablation Consumption Value by Type (2021-2032)
6.2 North America Oncology Ablation Market Size by Application (2021-2032)
6.3 North America Oncology Ablation Market Size by Country
6.3.1 North America Oncology Ablation Consumption Value by Country (2021-2032)
6.3.2 United States Oncology Ablation Market Size and Forecast (2021-2032)
6.3.3 Canada Oncology Ablation Market Size and Forecast (2021-2032)
6.3.4 Mexico Oncology Ablation Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Oncology Ablation Consumption Value by Type (2021-2032)
7.2 Europe Oncology Ablation Consumption Value by Application (2021-2032)
7.3 Europe Oncology Ablation Market Size by Country
7.3.1 Europe Oncology Ablation Consumption Value by Country (2021-2032)
7.3.2 Germany Oncology Ablation Market Size and Forecast (2021-2032)
7.3.3 France Oncology Ablation Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Oncology Ablation Market Size and Forecast (2021-2032)
7.3.5 Russia Oncology Ablation Market Size and Forecast (2021-2032)
7.3.6 Italy Oncology Ablation Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Oncology Ablation Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Oncology Ablation Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Oncology Ablation Market Size by Region
8.3.1 Asia-Pacific Oncology Ablation Consumption Value by Region (2021-2032)
8.3.2 China Oncology Ablation Market Size and Forecast (2021-2032)
8.3.3 Japan Oncology Ablation Market Size and Forecast (2021-2032)
8.3.4 South Korea Oncology Ablation Market Size and Forecast (2021-2032)
8.3.5 India Oncology Ablation Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Oncology Ablation Market Size and Forecast (2021-2032)
8.3.7 Australia Oncology Ablation Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Oncology Ablation Consumption Value by Type (2021-2032)
9.2 South America Oncology Ablation Consumption Value by Application (2021-2032)
9.3 South America Oncology Ablation Market Size by Country
9.3.1 South America Oncology Ablation Consumption Value by Country (2021-2032)
9.3.2 Brazil Oncology Ablation Market Size and Forecast (2021-2032)
9.3.3 Argentina Oncology Ablation Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Oncology Ablation Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Oncology Ablation Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Oncology Ablation Market Size by Country
10.3.1 Middle East & Africa Oncology Ablation Consumption Value by Country (2021-2032)
10.3.2 Turkey Oncology Ablation Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Oncology Ablation Market Size and Forecast (2021-2032)
10.3.4 UAE Oncology Ablation Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Oncology Ablation Market Drivers
11.2 Oncology Ablation Market Restraints
11.3 Oncology Ablation Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Oncology Ablation Industry Chain
12.2 Oncology Ablation Upstream Analysis
12.3 Oncology Ablation Midstream Analysis
12.4 Oncology Ablation Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncology Ablation by Type
1.3.1 Overview: Global Oncology Ablation Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Oncology Ablation Consumption Value Market Share by Type in 2025
1.3.3 Microwave Ablation
1.3.4 Radiofrequency Ablation
1.3.5 Cryoablation
1.3.6 High-Intensity Focused Ultrasound (HIFU)
1.3.7 Others
1.4 Classification of Oncology Ablation by Energy Source
1.4.1 Overview: Global Oncology Ablation Market Size by Energy Source: 2021 Versus 2025 Versus 2032
1.4.2 Global Oncology Ablation Consumption Value Market Share by Energy Source in 2025
1.4.3 Thermal
1.4.4 Cryogenic
1.5 Classification of Oncology Ablation by Procedure Type
1.5.1 Overview: Global Oncology Ablation Market Size by Procedure Type: 2021 Versus 2025 Versus 2032
1.5.2 Global Oncology Ablation Consumption Value Market Share by Procedure Type in 2025
1.5.3 Percutaneous
1.5.4 Laparoscopic
1.5.5 Open
1.6 Global Oncology Ablation Market by Application
1.6.1 Overview: Global Oncology Ablation Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Liver Cancer
1.6.3 Lung Cancer
1.6.4 Breast Cancer
1.6.5 Other
1.7 Global Oncology Ablation Market Size & Forecast
1.8 Global Oncology Ablation Market Size and Forecast by Region
1.8.1 Global Oncology Ablation Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Oncology Ablation Market Size by Region, (2021-2032)
1.8.3 North America Oncology Ablation Market Size and Prospect (2021-2032)
1.8.4 Europe Oncology Ablation Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Oncology Ablation Market Size and Prospect (2021-2032)
1.8.6 South America Oncology Ablation Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Oncology Ablation Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Chongqing Haifu Medical
2.1.1 Chongqing Haifu Medical Details
2.1.2 Chongqing Haifu Medical Major Business
2.1.3 Chongqing Haifu Medical Oncology Ablation Product and Solutions
2.1.4 Chongqing Haifu Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Chongqing Haifu Medical Recent Developments and Future Plans
2.2 AngioDynamics
2.2.1 AngioDynamics Details
2.2.2 AngioDynamics Major Business
2.2.3 AngioDynamics Oncology Ablation Product and Solutions
2.2.4 AngioDynamics Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 AngioDynamics Recent Developments and Future Plans
2.3 Boston Scientific
2.3.1 Boston Scientific Details
2.3.2 Boston Scientific Major Business
2.3.3 Boston Scientific Oncology Ablation Product and Solutions
2.3.4 Boston Scientific Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Boston Scientific Recent Developments and Future Plans
2.4 Medtronic
2.4.1 Medtronic Details
2.4.2 Medtronic Major Business
2.4.3 Medtronic Oncology Ablation Product and Solutions
2.4.4 Medtronic Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Medtronic Recent Developments and Future Plans
2.5 Yigao Medical
2.5.1 Yigao Medical Details
2.5.2 Yigao Medical Major Business
2.5.3 Yigao Medical Oncology Ablation Product and Solutions
2.5.4 Yigao Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Yigao Medical Recent Developments and Future Plans
2.6 Haijieya
2.6.1 Haijieya Details
2.6.2 Haijieya Major Business
2.6.3 Haijieya Oncology Ablation Product and Solutions
2.6.4 Haijieya Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Haijieya Recent Developments and Future Plans
2.7 Beijing Weierfu
2.7.1 Beijing Weierfu Details
2.7.2 Beijing Weierfu Major Business
2.7.3 Beijing Weierfu Oncology Ablation Product and Solutions
2.7.4 Beijing Weierfu Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Beijing Weierfu Recent Developments and Future Plans
2.8 Micro Tech Medical
2.8.1 Micro Tech Medical Details
2.8.2 Micro Tech Medical Major Business
2.8.3 Micro Tech Medical Oncology Ablation Product and Solutions
2.8.4 Micro Tech Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Micro Tech Medical Recent Developments and Future Plans
2.9 Better Medical
2.9.1 Better Medical Details
2.9.2 Better Medical Major Business
2.9.3 Better Medical Oncology Ablation Product and Solutions
2.9.4 Better Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Better Medical Recent Developments and Future Plans
2.10 Vison Medical
2.10.1 Vison Medical Details
2.10.2 Vison Medical Major Business
2.10.3 Vison Medical Oncology Ablation Product and Solutions
2.10.4 Vison Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Vison Medical Recent Developments and Future Plans
2.11 Shanghai Maide
2.11.1 Shanghai Maide Details
2.11.2 Shanghai Maide Major Business
2.11.3 Shanghai Maide Oncology Ablation Product and Solutions
2.11.4 Shanghai Maide Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Shanghai Maide Recent Developments and Future Plans
2.12 HealthTronics
2.12.1 HealthTronics Details
2.12.2 HealthTronics Major Business
2.12.3 HealthTronics Oncology Ablation Product and Solutions
2.12.4 HealthTronics Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 HealthTronics Recent Developments and Future Plans
2.13 J &J
2.13.1 J &J Details
2.13.2 J &J Major Business
2.13.3 J &J Oncology Ablation Product and Solutions
2.13.4 J &J Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 J &J Recent Developments and Future Plans
2.14 EDAP TMS
2.14.1 EDAP TMS Details
2.14.2 EDAP TMS Major Business
2.14.3 EDAP TMS Oncology Ablation Product and Solutions
2.14.4 EDAP TMS Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 EDAP TMS Recent Developments and Future Plans
2.15 Sonacare Medical
2.15.1 Sonacare Medical Details
2.15.2 Sonacare Medical Major Business
2.15.3 Sonacare Medical Oncology Ablation Product and Solutions
2.15.4 Sonacare Medical Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Sonacare Medical Recent Developments and Future Plans
2.16 Misonix
2.16.1 Misonix Details
2.16.2 Misonix Major Business
2.16.3 Misonix Oncology Ablation Product and Solutions
2.16.4 Misonix Oncology Ablation Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Misonix Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Oncology Ablation Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Oncology Ablation by Company Revenue
3.2.2 Top 3 Oncology Ablation Players Market Share in 2025
3.2.3 Top 6 Oncology Ablation Players Market Share in 2025
3.3 Oncology Ablation Market: Overall Company Footprint Analysis
3.3.1 Oncology Ablation Market: Region Footprint
3.3.2 Oncology Ablation Market: Company Product Type Footprint
3.3.3 Oncology Ablation Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Oncology Ablation Consumption Value and Market Share by Type (2021-2026)
4.2 Global Oncology Ablation Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Oncology Ablation Consumption Value Market Share by Application (2021-2026)
5.2 Global Oncology Ablation Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Oncology Ablation Consumption Value by Type (2021-2032)
6.2 North America Oncology Ablation Market Size by Application (2021-2032)
6.3 North America Oncology Ablation Market Size by Country
6.3.1 North America Oncology Ablation Consumption Value by Country (2021-2032)
6.3.2 United States Oncology Ablation Market Size and Forecast (2021-2032)
6.3.3 Canada Oncology Ablation Market Size and Forecast (2021-2032)
6.3.4 Mexico Oncology Ablation Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Oncology Ablation Consumption Value by Type (2021-2032)
7.2 Europe Oncology Ablation Consumption Value by Application (2021-2032)
7.3 Europe Oncology Ablation Market Size by Country
7.3.1 Europe Oncology Ablation Consumption Value by Country (2021-2032)
7.3.2 Germany Oncology Ablation Market Size and Forecast (2021-2032)
7.3.3 France Oncology Ablation Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Oncology Ablation Market Size and Forecast (2021-2032)
7.3.5 Russia Oncology Ablation Market Size and Forecast (2021-2032)
7.3.6 Italy Oncology Ablation Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Oncology Ablation Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Oncology Ablation Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Oncology Ablation Market Size by Region
8.3.1 Asia-Pacific Oncology Ablation Consumption Value by Region (2021-2032)
8.3.2 China Oncology Ablation Market Size and Forecast (2021-2032)
8.3.3 Japan Oncology Ablation Market Size and Forecast (2021-2032)
8.3.4 South Korea Oncology Ablation Market Size and Forecast (2021-2032)
8.3.5 India Oncology Ablation Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Oncology Ablation Market Size and Forecast (2021-2032)
8.3.7 Australia Oncology Ablation Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Oncology Ablation Consumption Value by Type (2021-2032)
9.2 South America Oncology Ablation Consumption Value by Application (2021-2032)
9.3 South America Oncology Ablation Market Size by Country
9.3.1 South America Oncology Ablation Consumption Value by Country (2021-2032)
9.3.2 Brazil Oncology Ablation Market Size and Forecast (2021-2032)
9.3.3 Argentina Oncology Ablation Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Oncology Ablation Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Oncology Ablation Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Oncology Ablation Market Size by Country
10.3.1 Middle East & Africa Oncology Ablation Consumption Value by Country (2021-2032)
10.3.2 Turkey Oncology Ablation Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Oncology Ablation Market Size and Forecast (2021-2032)
10.3.4 UAE Oncology Ablation Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Oncology Ablation Market Drivers
11.2 Oncology Ablation Market Restraints
11.3 Oncology Ablation Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Oncology Ablation Industry Chain
12.2 Oncology Ablation Upstream Analysis
12.3 Oncology Ablation Midstream Analysis
12.4 Oncology Ablation Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Oncology Ablation Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Oncology Ablation Consumption Value by Energy Source, (USD Million), 2021 & 2025 & 2032
Table 3. Global Oncology Ablation Consumption Value by Procedure Type, (USD Million), 2021 & 2025 & 2032
Table 4. Global Oncology Ablation Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Oncology Ablation Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Oncology Ablation Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Chongqing Haifu Medical Company Information, Head Office, and Major Competitors
Table 8. Chongqing Haifu Medical Major Business
Table 9. Chongqing Haifu Medical Oncology Ablation Product and Solutions
Table 10. Chongqing Haifu Medical Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Chongqing Haifu Medical Recent Developments and Future Plans
Table 12. AngioDynamics Company Information, Head Office, and Major Competitors
Table 13. AngioDynamics Major Business
Table 14. AngioDynamics Oncology Ablation Product and Solutions
Table 15. AngioDynamics Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. AngioDynamics Recent Developments and Future Plans
Table 17. Boston Scientific Company Information, Head Office, and Major Competitors
Table 18. Boston Scientific Major Business
Table 19. Boston Scientific Oncology Ablation Product and Solutions
Table 20. Boston Scientific Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Medtronic Company Information, Head Office, and Major Competitors
Table 22. Medtronic Major Business
Table 23. Medtronic Oncology Ablation Product and Solutions
Table 24. Medtronic Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Medtronic Recent Developments and Future Plans
Table 26. Yigao Medical Company Information, Head Office, and Major Competitors
Table 27. Yigao Medical Major Business
Table 28. Yigao Medical Oncology Ablation Product and Solutions
Table 29. Yigao Medical Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Yigao Medical Recent Developments and Future Plans
Table 31. Haijieya Company Information, Head Office, and Major Competitors
Table 32. Haijieya Major Business
Table 33. Haijieya Oncology Ablation Product and Solutions
Table 34. Haijieya Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Haijieya Recent Developments and Future Plans
Table 36. Beijing Weierfu Company Information, Head Office, and Major Competitors
Table 37. Beijing Weierfu Major Business
Table 38. Beijing Weierfu Oncology Ablation Product and Solutions
Table 39. Beijing Weierfu Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Beijing Weierfu Recent Developments and Future Plans
Table 41. Micro Tech Medical Company Information, Head Office, and Major Competitors
Table 42. Micro Tech Medical Major Business
Table 43. Micro Tech Medical Oncology Ablation Product and Solutions
Table 44. Micro Tech Medical Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Micro Tech Medical Recent Developments and Future Plans
Table 46. Better Medical Company Information, Head Office, and Major Competitors
Table 47. Better Medical Major Business
Table 48. Better Medical Oncology Ablation Product and Solutions
Table 49. Better Medical Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Better Medical Recent Developments and Future Plans
Table 51. Vison Medical Company Information, Head Office, and Major Competitors
Table 52. Vison Medical Major Business
Table 53. Vison Medical Oncology Ablation Product and Solutions
Table 54. Vison Medical Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Vison Medical Recent Developments and Future Plans
Table 56. Shanghai Maide Company Information, Head Office, and Major Competitors
Table 57. Shanghai Maide Major Business
Table 58. Shanghai Maide Oncology Ablation Product and Solutions
Table 59. Shanghai Maide Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Shanghai Maide Recent Developments and Future Plans
Table 61. HealthTronics Company Information, Head Office, and Major Competitors
Table 62. HealthTronics Major Business
Table 63. HealthTronics Oncology Ablation Product and Solutions
Table 64. HealthTronics Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. HealthTronics Recent Developments and Future Plans
Table 66. J &J Company Information, Head Office, and Major Competitors
Table 67. J &J Major Business
Table 68. J &J Oncology Ablation Product and Solutions
Table 69. J &J Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. J &J Recent Developments and Future Plans
Table 71. EDAP TMS Company Information, Head Office, and Major Competitors
Table 72. EDAP TMS Major Business
Table 73. EDAP TMS Oncology Ablation Product and Solutions
Table 74. EDAP TMS Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. EDAP TMS Recent Developments and Future Plans
Table 76. Sonacare Medical Company Information, Head Office, and Major Competitors
Table 77. Sonacare Medical Major Business
Table 78. Sonacare Medical Oncology Ablation Product and Solutions
Table 79. Sonacare Medical Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Sonacare Medical Recent Developments and Future Plans
Table 81. Misonix Company Information, Head Office, and Major Competitors
Table 82. Misonix Major Business
Table 83. Misonix Oncology Ablation Product and Solutions
Table 84. Misonix Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Misonix Recent Developments and Future Plans
Table 86. Global Oncology Ablation Revenue (USD Million) by Players (2021-2026)
Table 87. Global Oncology Ablation Revenue Share by Players (2021-2026)
Table 88. Breakdown of Oncology Ablation by Company Type (Tier 1, Tier 2, and Tier 3)
Table 89. Market Position of Players in Oncology Ablation, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 90. Head Office of Key Oncology Ablation Players
Table 91. Oncology Ablation Market: Company Product Type Footprint
Table 92. Oncology Ablation Market: Company Product Application Footprint
Table 93. Oncology Ablation New Market Entrants and Barriers to Market Entry
Table 94. Oncology Ablation Mergers, Acquisition, Agreements, and Collaborations
Table 95. Global Oncology Ablation Consumption Value (USD Million) by Type (2021-2026)
Table 96. Global Oncology Ablation Consumption Value Share by Type (2021-2026)
Table 97. Global Oncology Ablation Consumption Value Forecast by Type (2027-2032)
Table 98. Global Oncology Ablation Consumption Value by Application (2021-2026)
Table 99. Global Oncology Ablation Consumption Value Forecast by Application (2027-2032)
Table 100. North America Oncology Ablation Consumption Value by Type (2021-2026) & (USD Million)
Table 101. North America Oncology Ablation Consumption Value by Type (2027-2032) & (USD Million)
Table 102. North America Oncology Ablation Consumption Value by Application (2021-2026) & (USD Million)
Table 103. North America Oncology Ablation Consumption Value by Application (2027-2032) & (USD Million)
Table 104. North America Oncology Ablation Consumption Value by Country (2021-2026) & (USD Million)
Table 105. North America Oncology Ablation Consumption Value by Country (2027-2032) & (USD Million)
Table 106. Europe Oncology Ablation Consumption Value by Type (2021-2026) & (USD Million)
Table 107. Europe Oncology Ablation Consumption Value by Type (2027-2032) & (USD Million)
Table 108. Europe Oncology Ablation Consumption Value by Application (2021-2026) & (USD Million)
Table 109. Europe Oncology Ablation Consumption Value by Application (2027-2032) & (USD Million)
Table 110. Europe Oncology Ablation Consumption Value by Country (2021-2026) & (USD Million)
Table 111. Europe Oncology Ablation Consumption Value by Country (2027-2032) & (USD Million)
Table 112. Asia-Pacific Oncology Ablation Consumption Value by Type (2021-2026) & (USD Million)
Table 113. Asia-Pacific Oncology Ablation Consumption Value by Type (2027-2032) & (USD Million)
Table 114. Asia-Pacific Oncology Ablation Consumption Value by Application (2021-2026) & (USD Million)
Table 115. Asia-Pacific Oncology Ablation Consumption Value by Application (2027-2032) & (USD Million)
Table 116. Asia-Pacific Oncology Ablation Consumption Value by Region (2021-2026) & (USD Million)
Table 117. Asia-Pacific Oncology Ablation Consumption Value by Region (2027-2032) & (USD Million)
Table 118. South America Oncology Ablation Consumption Value by Type (2021-2026) & (USD Million)
Table 119. South America Oncology Ablation Consumption Value by Type (2027-2032) & (USD Million)
Table 120. South America Oncology Ablation Consumption Value by Application (2021-2026) & (USD Million)
Table 121. South America Oncology Ablation Consumption Value by Application (2027-2032) & (USD Million)
Table 122. South America Oncology Ablation Consumption Value by Country (2021-2026) & (USD Million)
Table 123. South America Oncology Ablation Consumption Value by Country (2027-2032) & (USD Million)
Table 124. Middle East & Africa Oncology Ablation Consumption Value by Type (2021-2026) & (USD Million)
Table 125. Middle East & Africa Oncology Ablation Consumption Value by Type (2027-2032) & (USD Million)
Table 126. Middle East & Africa Oncology Ablation Consumption Value by Application (2021-2026) & (USD Million)
Table 127. Middle East & Africa Oncology Ablation Consumption Value by Application (2027-2032) & (USD Million)
Table 128. Middle East & Africa Oncology Ablation Consumption Value by Country (2021-2026) & (USD Million)
Table 129. Middle East & Africa Oncology Ablation Consumption Value by Country (2027-2032) & (USD Million)
Table 130. Global Key Players of Oncology Ablation Upstream (Raw Materials)
Table 131. Global Oncology Ablation Typical Customers
Table 1. Global Oncology Ablation Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Oncology Ablation Consumption Value by Energy Source, (USD Million), 2021 & 2025 & 2032
Table 3. Global Oncology Ablation Consumption Value by Procedure Type, (USD Million), 2021 & 2025 & 2032
Table 4. Global Oncology Ablation Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Oncology Ablation Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Oncology Ablation Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Chongqing Haifu Medical Company Information, Head Office, and Major Competitors
Table 8. Chongqing Haifu Medical Major Business
Table 9. Chongqing Haifu Medical Oncology Ablation Product and Solutions
Table 10. Chongqing Haifu Medical Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Chongqing Haifu Medical Recent Developments and Future Plans
Table 12. AngioDynamics Company Information, Head Office, and Major Competitors
Table 13. AngioDynamics Major Business
Table 14. AngioDynamics Oncology Ablation Product and Solutions
Table 15. AngioDynamics Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. AngioDynamics Recent Developments and Future Plans
Table 17. Boston Scientific Company Information, Head Office, and Major Competitors
Table 18. Boston Scientific Major Business
Table 19. Boston Scientific Oncology Ablation Product and Solutions
Table 20. Boston Scientific Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Medtronic Company Information, Head Office, and Major Competitors
Table 22. Medtronic Major Business
Table 23. Medtronic Oncology Ablation Product and Solutions
Table 24. Medtronic Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Medtronic Recent Developments and Future Plans
Table 26. Yigao Medical Company Information, Head Office, and Major Competitors
Table 27. Yigao Medical Major Business
Table 28. Yigao Medical Oncology Ablation Product and Solutions
Table 29. Yigao Medical Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Yigao Medical Recent Developments and Future Plans
Table 31. Haijieya Company Information, Head Office, and Major Competitors
Table 32. Haijieya Major Business
Table 33. Haijieya Oncology Ablation Product and Solutions
Table 34. Haijieya Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Haijieya Recent Developments and Future Plans
Table 36. Beijing Weierfu Company Information, Head Office, and Major Competitors
Table 37. Beijing Weierfu Major Business
Table 38. Beijing Weierfu Oncology Ablation Product and Solutions
Table 39. Beijing Weierfu Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Beijing Weierfu Recent Developments and Future Plans
Table 41. Micro Tech Medical Company Information, Head Office, and Major Competitors
Table 42. Micro Tech Medical Major Business
Table 43. Micro Tech Medical Oncology Ablation Product and Solutions
Table 44. Micro Tech Medical Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Micro Tech Medical Recent Developments and Future Plans
Table 46. Better Medical Company Information, Head Office, and Major Competitors
Table 47. Better Medical Major Business
Table 48. Better Medical Oncology Ablation Product and Solutions
Table 49. Better Medical Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Better Medical Recent Developments and Future Plans
Table 51. Vison Medical Company Information, Head Office, and Major Competitors
Table 52. Vison Medical Major Business
Table 53. Vison Medical Oncology Ablation Product and Solutions
Table 54. Vison Medical Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Vison Medical Recent Developments and Future Plans
Table 56. Shanghai Maide Company Information, Head Office, and Major Competitors
Table 57. Shanghai Maide Major Business
Table 58. Shanghai Maide Oncology Ablation Product and Solutions
Table 59. Shanghai Maide Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Shanghai Maide Recent Developments and Future Plans
Table 61. HealthTronics Company Information, Head Office, and Major Competitors
Table 62. HealthTronics Major Business
Table 63. HealthTronics Oncology Ablation Product and Solutions
Table 64. HealthTronics Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. HealthTronics Recent Developments and Future Plans
Table 66. J &J Company Information, Head Office, and Major Competitors
Table 67. J &J Major Business
Table 68. J &J Oncology Ablation Product and Solutions
Table 69. J &J Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. J &J Recent Developments and Future Plans
Table 71. EDAP TMS Company Information, Head Office, and Major Competitors
Table 72. EDAP TMS Major Business
Table 73. EDAP TMS Oncology Ablation Product and Solutions
Table 74. EDAP TMS Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. EDAP TMS Recent Developments and Future Plans
Table 76. Sonacare Medical Company Information, Head Office, and Major Competitors
Table 77. Sonacare Medical Major Business
Table 78. Sonacare Medical Oncology Ablation Product and Solutions
Table 79. Sonacare Medical Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Sonacare Medical Recent Developments and Future Plans
Table 81. Misonix Company Information, Head Office, and Major Competitors
Table 82. Misonix Major Business
Table 83. Misonix Oncology Ablation Product and Solutions
Table 84. Misonix Oncology Ablation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Misonix Recent Developments and Future Plans
Table 86. Global Oncology Ablation Revenue (USD Million) by Players (2021-2026)
Table 87. Global Oncology Ablation Revenue Share by Players (2021-2026)
Table 88. Breakdown of Oncology Ablation by Company Type (Tier 1, Tier 2, and Tier 3)
Table 89. Market Position of Players in Oncology Ablation, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 90. Head Office of Key Oncology Ablation Players
Table 91. Oncology Ablation Market: Company Product Type Footprint
Table 92. Oncology Ablation Market: Company Product Application Footprint
Table 93. Oncology Ablation New Market Entrants and Barriers to Market Entry
Table 94. Oncology Ablation Mergers, Acquisition, Agreements, and Collaborations
Table 95. Global Oncology Ablation Consumption Value (USD Million) by Type (2021-2026)
Table 96. Global Oncology Ablation Consumption Value Share by Type (2021-2026)
Table 97. Global Oncology Ablation Consumption Value Forecast by Type (2027-2032)
Table 98. Global Oncology Ablation Consumption Value by Application (2021-2026)
Table 99. Global Oncology Ablation Consumption Value Forecast by Application (2027-2032)
Table 100. North America Oncology Ablation Consumption Value by Type (2021-2026) & (USD Million)
Table 101. North America Oncology Ablation Consumption Value by Type (2027-2032) & (USD Million)
Table 102. North America Oncology Ablation Consumption Value by Application (2021-2026) & (USD Million)
Table 103. North America Oncology Ablation Consumption Value by Application (2027-2032) & (USD Million)
Table 104. North America Oncology Ablation Consumption Value by Country (2021-2026) & (USD Million)
Table 105. North America Oncology Ablation Consumption Value by Country (2027-2032) & (USD Million)
Table 106. Europe Oncology Ablation Consumption Value by Type (2021-2026) & (USD Million)
Table 107. Europe Oncology Ablation Consumption Value by Type (2027-2032) & (USD Million)
Table 108. Europe Oncology Ablation Consumption Value by Application (2021-2026) & (USD Million)
Table 109. Europe Oncology Ablation Consumption Value by Application (2027-2032) & (USD Million)
Table 110. Europe Oncology Ablation Consumption Value by Country (2021-2026) & (USD Million)
Table 111. Europe Oncology Ablation Consumption Value by Country (2027-2032) & (USD Million)
Table 112. Asia-Pacific Oncology Ablation Consumption Value by Type (2021-2026) & (USD Million)
Table 113. Asia-Pacific Oncology Ablation Consumption Value by Type (2027-2032) & (USD Million)
Table 114. Asia-Pacific Oncology Ablation Consumption Value by Application (2021-2026) & (USD Million)
Table 115. Asia-Pacific Oncology Ablation Consumption Value by Application (2027-2032) & (USD Million)
Table 116. Asia-Pacific Oncology Ablation Consumption Value by Region (2021-2026) & (USD Million)
Table 117. Asia-Pacific Oncology Ablation Consumption Value by Region (2027-2032) & (USD Million)
Table 118. South America Oncology Ablation Consumption Value by Type (2021-2026) & (USD Million)
Table 119. South America Oncology Ablation Consumption Value by Type (2027-2032) & (USD Million)
Table 120. South America Oncology Ablation Consumption Value by Application (2021-2026) & (USD Million)
Table 121. South America Oncology Ablation Consumption Value by Application (2027-2032) & (USD Million)
Table 122. South America Oncology Ablation Consumption Value by Country (2021-2026) & (USD Million)
Table 123. South America Oncology Ablation Consumption Value by Country (2027-2032) & (USD Million)
Table 124. Middle East & Africa Oncology Ablation Consumption Value by Type (2021-2026) & (USD Million)
Table 125. Middle East & Africa Oncology Ablation Consumption Value by Type (2027-2032) & (USD Million)
Table 126. Middle East & Africa Oncology Ablation Consumption Value by Application (2021-2026) & (USD Million)
Table 127. Middle East & Africa Oncology Ablation Consumption Value by Application (2027-2032) & (USD Million)
Table 128. Middle East & Africa Oncology Ablation Consumption Value by Country (2021-2026) & (USD Million)
Table 129. Middle East & Africa Oncology Ablation Consumption Value by Country (2027-2032) & (USD Million)
Table 130. Global Key Players of Oncology Ablation Upstream (Raw Materials)
Table 131. Global Oncology Ablation Typical Customers
LIST OF FIGURES
Figure 1. Oncology Ablation Picture
Figure 2. Global Oncology Ablation Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Oncology Ablation Consumption Value Market Share by Type in 2025
Figure 4. Microwave Ablation
Figure 5. Radiofrequency Ablation
Figure 6. Cryoablation
Figure 7. High-Intensity Focused Ultrasound (HIFU)
Figure 8. Others
Figure 9. Global Oncology Ablation Consumption Value by Energy Source, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Oncology Ablation Consumption Value Market Share by Energy Source in 2025
Figure 11. Thermal
Figure 12. Cryogenic
Figure 13. Global Oncology Ablation Consumption Value by Procedure Type, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Oncology Ablation Consumption Value Market Share by Procedure Type in 2025
Figure 15. Percutaneous
Figure 16. Laparoscopic
Figure 17. Open
Figure 18. Global Oncology Ablation Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Oncology Ablation Consumption Value Market Share by Application in 2025
Figure 20. Liver Cancer Picture
Figure 21. Lung Cancer Picture
Figure 22. Breast Cancer Picture
Figure 23. Other Picture
Figure 24. Global Oncology Ablation Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global Oncology Ablation Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Market Oncology Ablation Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 27. Global Oncology Ablation Consumption Value Market Share by Region (2021-2032)
Figure 28. Global Oncology Ablation Consumption Value Market Share by Region in 2025
Figure 29. North America Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 32. South America Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 34. Company Three Recent Developments and Future Plans
Figure 35. Global Oncology Ablation Revenue Share by Players in 2025
Figure 36. Oncology Ablation Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 37. Market Share of Oncology Ablation by Player Revenue in 2025
Figure 38. Top 3 Oncology Ablation Players Market Share in 2025
Figure 39. Top 6 Oncology Ablation Players Market Share in 2025
Figure 40. Global Oncology Ablation Consumption Value Share by Type (2021-2026)
Figure 41. Global Oncology Ablation Market Share Forecast by Type (2027-2032)
Figure 42. Global Oncology Ablation Consumption Value Share by Application (2021-2026)
Figure 43. Global Oncology Ablation Market Share Forecast by Application (2027-2032)
Figure 44. North America Oncology Ablation Consumption Value Market Share by Type (2021-2032)
Figure 45. North America Oncology Ablation Consumption Value Market Share by Application (2021-2032)
Figure 46. North America Oncology Ablation Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Oncology Ablation Consumption Value Market Share by Type (2021-2032)
Figure 51. Europe Oncology Ablation Consumption Value Market Share by Application (2021-2032)
Figure 52. Europe Oncology Ablation Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 54. France Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific Oncology Ablation Consumption Value Market Share by Type (2021-2032)
Figure 59. Asia-Pacific Oncology Ablation Consumption Value Market Share by Application (2021-2032)
Figure 60. Asia-Pacific Oncology Ablation Consumption Value Market Share by Region (2021-2032)
Figure 61. China Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 64. India Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 67. South America Oncology Ablation Consumption Value Market Share by Type (2021-2032)
Figure 68. South America Oncology Ablation Consumption Value Market Share by Application (2021-2032)
Figure 69. South America Oncology Ablation Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa Oncology Ablation Consumption Value Market Share by Type (2021-2032)
Figure 73. Middle East & Africa Oncology Ablation Consumption Value Market Share by Application (2021-2032)
Figure 74. Middle East & Africa Oncology Ablation Consumption Value Market Share by Country (2021-2032)
Figure 75. Turkey Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 77. UAE Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 78. Oncology Ablation Market Drivers
Figure 79. Oncology Ablation Market Restraints
Figure 80. Oncology Ablation Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Oncology Ablation Industrial Chain
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Oncology Ablation Picture
Figure 2. Global Oncology Ablation Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Oncology Ablation Consumption Value Market Share by Type in 2025
Figure 4. Microwave Ablation
Figure 5. Radiofrequency Ablation
Figure 6. Cryoablation
Figure 7. High-Intensity Focused Ultrasound (HIFU)
Figure 8. Others
Figure 9. Global Oncology Ablation Consumption Value by Energy Source, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Oncology Ablation Consumption Value Market Share by Energy Source in 2025
Figure 11. Thermal
Figure 12. Cryogenic
Figure 13. Global Oncology Ablation Consumption Value by Procedure Type, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Oncology Ablation Consumption Value Market Share by Procedure Type in 2025
Figure 15. Percutaneous
Figure 16. Laparoscopic
Figure 17. Open
Figure 18. Global Oncology Ablation Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Oncology Ablation Consumption Value Market Share by Application in 2025
Figure 20. Liver Cancer Picture
Figure 21. Lung Cancer Picture
Figure 22. Breast Cancer Picture
Figure 23. Other Picture
Figure 24. Global Oncology Ablation Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global Oncology Ablation Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Market Oncology Ablation Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 27. Global Oncology Ablation Consumption Value Market Share by Region (2021-2032)
Figure 28. Global Oncology Ablation Consumption Value Market Share by Region in 2025
Figure 29. North America Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 32. South America Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 34. Company Three Recent Developments and Future Plans
Figure 35. Global Oncology Ablation Revenue Share by Players in 2025
Figure 36. Oncology Ablation Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 37. Market Share of Oncology Ablation by Player Revenue in 2025
Figure 38. Top 3 Oncology Ablation Players Market Share in 2025
Figure 39. Top 6 Oncology Ablation Players Market Share in 2025
Figure 40. Global Oncology Ablation Consumption Value Share by Type (2021-2026)
Figure 41. Global Oncology Ablation Market Share Forecast by Type (2027-2032)
Figure 42. Global Oncology Ablation Consumption Value Share by Application (2021-2026)
Figure 43. Global Oncology Ablation Market Share Forecast by Application (2027-2032)
Figure 44. North America Oncology Ablation Consumption Value Market Share by Type (2021-2032)
Figure 45. North America Oncology Ablation Consumption Value Market Share by Application (2021-2032)
Figure 46. North America Oncology Ablation Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Oncology Ablation Consumption Value Market Share by Type (2021-2032)
Figure 51. Europe Oncology Ablation Consumption Value Market Share by Application (2021-2032)
Figure 52. Europe Oncology Ablation Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 54. France Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific Oncology Ablation Consumption Value Market Share by Type (2021-2032)
Figure 59. Asia-Pacific Oncology Ablation Consumption Value Market Share by Application (2021-2032)
Figure 60. Asia-Pacific Oncology Ablation Consumption Value Market Share by Region (2021-2032)
Figure 61. China Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 64. India Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 67. South America Oncology Ablation Consumption Value Market Share by Type (2021-2032)
Figure 68. South America Oncology Ablation Consumption Value Market Share by Application (2021-2032)
Figure 69. South America Oncology Ablation Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa Oncology Ablation Consumption Value Market Share by Type (2021-2032)
Figure 73. Middle East & Africa Oncology Ablation Consumption Value Market Share by Application (2021-2032)
Figure 74. Middle East & Africa Oncology Ablation Consumption Value Market Share by Country (2021-2032)
Figure 75. Turkey Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 77. UAE Oncology Ablation Consumption Value (2021-2032) & (USD Million)
Figure 78. Oncology Ablation Market Drivers
Figure 79. Oncology Ablation Market Restraints
Figure 80. Oncology Ablation Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Oncology Ablation Industrial Chain
Figure 83. Methodology
Figure 84. Research Process and Data Source
